| General Information of Drug Metabolite (DM) (ID: DM017884) |
| DM Name |
BMS-204352 Metabolite M2
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
BMS-204352
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| BMS-204352 |
DR3058
|
Discontinued in Phase 3 |
Nerve injury |
|
|
| References |
| 1 |
Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
